BioSpace News Archive

CytRx Corporation (NASDAQ: CYTR) today highlighted that an abstract submitted by aldoxorubicin licensee NantCell, Inc., a private subsidiary of NantWorks, LLC, has been selected for a poster presentation at the upcoming American Society of Clinical Oncology (ASCO) 2018 Annual Meeting, taking place June 1-5, 2018 in Chicago.

Biomerics and ATL Technology, in a joint venture (Biomerics ATL, LLC), announced on Tuesday, April 24, 2018, that they have entered into an agreement under which together they will acquire Catheter Research Inc. (CRI)'s assets in the Indianapolis and Costa Rica divisions.

The Feinstein Institute for Medical Research hosted Professor Sir Marc Feldmann as the Institute’s Marsh Lecturer.